$MDVN MEDIVATION, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MEDIVATION, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in MEDIVATION, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
MEDIVATION, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Adams Daniel | Director | 0 | 0 | Jun 02 2005 | |||
| Adams Daniel | Director | 0 | 0 | Mar 20 2007 | |||
| Adams Daniel | Director | 0 | 0 | Jul 18 2011 | |||
| Adams Daniel | Director | 5,807 | 0 | Jul 01 2014 | |||
| Bailey Gregory | Director | 0 | 0 | Aug 09 2005 | |||
| Bailey Gregory | Director | 347,321 | 0 | Nov 14 2011 | |||
| Bailey Gregory | Director | 691,101 | 0 | Nov 01 2012 | |||
| Bierly Rick | CFO (former) | 28,744 | 0 | May 09 2016 | |||
| BLICKENSTAFF KIM D | Director | 0 | 0 | Sep 30 2016 | |||
| BLICKENSTAFF KIM D | Director | 5,807 | 0 | Jul 01 2014 | |||
| BLICKENSTAFF KIM D | Director | 0 | 0 | Jun 02 2005 | |||
| BLICKENSTAFF KIM D | Director | 0 | 0 | Jul 20 2007 | |||
| BLICKENSTAFF KIM D | Director | 0 | 0 | Feb 09 2012 | |||
| CHAKRAVARTY SARVAJIT | VP of Medicinal Chemistry | 0 | 0 | Nov 03 2008 | |||
| Cohen Cheryl | Chief Commercial Officer | 10,400 | 0 | Dec 13 2011 | |||
| Cohen Cheryl | Chief Commercial Officer | 32,436 | 0 | Feb 20 2014 | |||
| DIGIANDOMENICO ANTHONY | Director | 145,288 | 0 | Jan 11 2005 | |||
| FALBERG KATHRYN E | Director | 0 | 0 | Sep 30 2016 | |||
| FALBERG KATHRYN E | Director | 11,057 | 0 | Jul 02 2013 | |||
| FALBERG KATHRYN E | Director | 13,307 | 0 | Jul 01 2014 | |||
| FIORETTI WILLIAM | Director | 0 | 0 | Oct 29 2003 | |||
| GORLIN STEVE | Director | 2,212,830 | 0 | Aug 09 2005 | |||
| Graham Dawn | Director | 0 | 0 | Sep 30 2016 | |||
| HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD. | 10% Owner | 1,050,055 | 0 | Oct 07 2008 | |||
| Hirmand Mohammad | Interim Chief Medical Officer | 0 | 0 | Sep 30 2016 | |||
| Hung David | President and CEO | 0 | 0 | Sep 30 2016 | |||
| Hung David | President and CEO | 1,649,651 | 0 | Jan 30 2006 | |||
| Hung David | President and CEO | 1,599,651 | 0 | Jun 07 2007 | |||
| Hung David | President and CEO | 1,089,274 | 0 | May 16 2012 | |||
| Hung David | President and CEO | 882,868 | 0 | Feb 18 2015 | |||
| Jarrett Jennifer | Chief Financial Officer | 0 | 0 | Sep 30 2016 | |||
| Kelsey Stephen Michael | SVP of New Projects | 21,000 | 0 | Feb 20 2014 | |||
| King Michael L | Director | 0 | 0 | Sep 30 2016 | |||
| Lobacki Joseph M | Chief Commercial Officer | 19,365 | 0 | Jan 05 2016 | |||
| Lobacki Joseph M | Chief Commercial Officer | 11,215 | 0 | Dec 15 2014 | |||
| Machado Clarence Patrick | Director | 0 | 0 | Sep 30 2016 | |||
| Machado Clarence Patrick | Sr. Vice President and CFO | 496,123 | 0 | Jan 30 2006 | |||
| Machado Clarence Patrick | Sr. Vice President and CFO | 476,123 | 0 | Jun 07 2007 | |||
| Machado Clarence Patrick | Chief Business Officer and CFO | 40,424 | 0 | Dec 18 2012 | |||
| Machado Clarence Patrick | Director | 31,500 | 0 | Feb 12 2015 | |||
| MARLETT CHRISTOPHER A | Chairman and Chief Exec. Off. | 0 | 0 | May 03 2004 | |||
| MARLETT CHRISTOPHER A | Director | 574,736 | 0 | Jan 11 2005 | |||
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10% Owner | 2,689,664 | 0 | Oct 12 2007 | |||
| McCourt Marion | Chief Operating Officer | 0 | 0 | Sep 30 2016 | |||
| PALEKAR ROHAN | Chief Commercial Officer | 16,666 | 0 | Apr 21 2011 | |||
| Powell Andrew Kenneth William | SVP, General Counsel & Crp Sec | 0 | 0 | Sep 30 2016 | |||
| Protter Andrew A | VP, Preclinical Development | 0 | 0 | Sep 15 2006 | |||
| Protter Andrew A | VP, Preclinical Development | 0 | 0 | Nov 03 2008 | |||
| QVT Associates GP LLC | 10% Owner | 3,331,729 | 0 | Jun 09 2011 | |||
| Rhodes Jennifer J | GC & Corporate Secretary | 11,090 | 0 | Mar 17 2015 | |||
| Seely Lynn | Chief Medical Officer | 0 | 0 | Jun 07 2007 | |||
| Seely Lynn | Chief Medical Officer | 59,022 | 0 | Jun 19 2014 | |||
| Seely Lynn | Chief Medical Officer | 96,694 | 0 | Feb 18 2015 | |||
| Selena Pharmeceuticals Inc | 10% Owner | 2,212,830 | 0 | Aug 18 2005 | |||
| Svoronos Dawn | Director | 16,989 | 0 | Oct 16 2014 | |||
| Templeman Thomas | SVP, Pharmaceutical Operations | 22,720 | 0 | Oct 01 2015 | |||
| VERNON W ANTHONY | Director | 0 | 0 | Sep 30 2016 | |||
| VERNON W ANTHONY | Director | 0 | 0 | Jul 18 2011 | |||
| VERNON W ANTHONY | Director | 12,639 | 0 | Jul 01 2014 | |||
| Yang Tseli Lily | VP, Finance and Accounting | 0 | 0 | Sep 30 2016 | |||
| YARNO WENDY L | Director | 0 | 0 | Sep 30 2016 | |||
| YARNO WENDY L | Director | 13,307 | 0 | Jul 01 2014 |